Dan Cohen | Executive Vice President |
Travis Mickle | President, Chief Executive Officer |
LaDuane Clifton | Chief Financial Officer |
Randall Stanicky | RBC Capital Markets |
Dewey Steadman | Canaccord |
David Solomon | Roth Capital Partners |
Good day, ladies and gentlemen, and welcome to KemPharm’s First Quarter 2018 Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] I’d now like to turn the conference over to Dan Cohen, Executive Vice President. Please begin.